Liao, J. et al. Single-cell RNA sequencing of human kidney. Sci. Data 7, 4 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agarwal, R. et al. Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes. N. Engl. J. Med. 393, 533–543 (2025).

Article  CAS  PubMed  Google Scholar 

Bassanese, G., Wlodkowski, T., Servais, A., Heidet, L., Roccatello, D. & Emma, F. et al. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results. Orphanet. J. Rare Dis. 16, 251 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Ng, M. S. Y., Kaur, G., Francis, R. S., Hawley, C. M. & Johnson, D. W. Drug repurposing for glomerular diseases: an underutilized resource. Nat. Rev. Nephrol. 20, 707–721 (2024).

Article  PubMed  Google Scholar 

Ashuntantang, G., Miljeteig, I. & Luyckx, V. A. Bedside rationing and moral distress in nephrologists in sub-Saharan Africa. BMC Nephrol. 23, 196 (2022).

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Reducing the burden of noncommunicable diseases through promotion of kidney health and strengthening prevention and control of kidney disease. WHO https://apps.who.int/gb/ebwha/pdf_files/EB156/B156_(20)-en.pdf (accessed 10 February 2025).

World Heart Federation. Driving sustainable action for circulatory health: white paper on circulatory health. World Heart Federation https://world-heart-federation.org/resource/white-paper-for-circulatory-health/drivingsustainableactionforcirculatoryhealth (2018).

Chen, T. K. et al. Advances in the management of chronic kidney disease. BMJ 383, e074216 (2023).

Article  PubMed  Google Scholar 

Beck, L. H. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 361, 11–21 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Remuzzi, G. et al. Rituximab for idiopathic membranous nephropathy. Lancet 360, 923–924 (2002).

Article  CAS  PubMed  Google Scholar 

Noris, M., Mescia, F. & Remuzzi, G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat. Rev. Nephrol. 8, 622–633 (2012).

Article  CAS  PubMed  Google Scholar 

Pullen, L. C. Xenotransplantation moves toward clinical trials. Am. J. Transplant. 24, 509–511 (2024).

Article  PubMed  Google Scholar 

Palmer, B. F. & Clegg, D. J. Kidney-protective effects of SGLT2 inhibitors. Clin. J. Am. Soc. Nephrol. 18, 279–289 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Devarajan, P. M. et al. Emerging role of clinical genetics in CKD. Kidney Med. 4, 100435 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Hu, T., Chitnis, N., Monos, D. & Dinh, A. Next-generation sequencing technologies: an overview. Hum. Immunol. 82, 801–811 (2021).

Article  CAS  PubMed  Google Scholar 

World Health Organization. Hypertension. WHO https://www.who.int/news-room/fact-sheets/detail/hypertension (accessed 27 February 2025).

Liu, H. et al. Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. Science 387, eadp4753 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, J. et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360, 758–763 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585–594 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abedini, A. et al. Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression. Nat. Genet. 56, 1712–1724 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neuen, B. L. et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria. Circulation 149, 450–462 (2024).

Article  CAS  PubMed  Google Scholar 

Berns, J. S., Glickman, A. & McCoy, M. S. Dialysis-facility joint-venture ownership — hidden conflicts of interest. N. Engl. J. Med. 379, 1295–1297 (2018).

Article  PubMed  Google Scholar 

Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990–2010. N. Engl. J. Med. 370, 1514–1523 (2014).

Article  CAS  PubMed  Google Scholar 

Ranchin, B. et al. Devices for long-term hemodialysis in small children — a plea for action. Kidney Int. 103, 1038–1040 (2023).

Article  PubMed  Google Scholar 

Deesker, L. J. et al. Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN. Nephrol. Dial. Transplant. https://doi.org/10.1093/ndt/gfaf035 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Rubin, R. It takes an average of 17 years for evidence to change practice — the burgeoning field of implementation science seeks to speed things up. JAMA 329, 1333–1336 (2023).

Article  PubMed  Google Scholar 

Neuen, B. L. et al. Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data. Lancet Reg. Health West Pac. 43, 100988 (2024).

PubMed  Google Scholar 

Moore, T. J., Zhang, H., Anderson, G. & Alexander, G. C. Estimated costs of pivotal trials for novel therapeutic agents approved by the US food and drug administration, 2015–2016. JAMA Intern. Med. 178, 1451–1457 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Tolvaptan (Jinarc) and polycystic kidney disease. Too many adverse effects, uncertain efficacy. Prescrire Int. 26, 262 (2017).

Google Scholar 

GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100–2132 (2024).

Article  Google Scholar 

Lou-Meda, R. & Pérez, J. B. Reducing the burden of chronic kidney disease in the world. Lancet 405, 1810 (2025).

Article  PubMed  Google Scholar 

Nangaku, M. et al. International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology. Kidney Int. 104, 36–45 (2023).

Article  PubMed  Google Scholar 

Vivante, A. Genetics of chronic kidney disease. N. Engl. J. Med. 391, 627–639 (2024).

Article  CAS  PubMed  Google Scholar 

Tasca, P. et al. Application of spatial-omics to the classification of kidney biopsy samples in transplantation. Nat. Rev. Nephrol. 20, 755–766 (2024).

Article  PubMed  Google Scholar 

Reznichenko, A. et al. Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine. Kidney Int 105, 1263–1278 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar